A CRO of a Different Breed

Preclinical and clinical Contract Research Organizations have their place. By using a CRO, biotechs and pharmaceutical brands of all sizes can expand their resources, gaining access to equipment and expertise. At the same time, they are able to streamline their focus on core expertise, minimize risks, and hopefully improve velocity from the initial drug concept to marketplace acceptance.

It makes perfect sense to outsource what you are not good at, especially if there is expertise readily available and meshes with your organization’s workflow. Successful CROs and uses thereof abound in the pharmaceutical industry from drug discovery to clinical trials, late-stage development, and manufacturing.

The CRO is a great resource for ready-made services that can plug into your organization’s needs across the drug development cycle. Eventually, though, you’ll need to do something that isn’t “on the existing menu”. When this is the case the services of the CRO become less relevant. You need something different. A new approach is warranted. Enter the Collaborative Research Organization, a CRO of a different breed.

Why Collaborate with ClearLight Biotechnologies?

ClearLight is a preclinical collaborative research organization. Unlike traditional contract research organizations that want to put you in a box, we listen and create an approach that answers your research question. Not all research follows a straight path. As our service engagement unfolds, new questions often arise. ClearLight will be there, helping you to See More Biology® in the complex tissue microenvironment.

“We have made assumptions about what happens with cancer and tumors based on the gold standard FFPE 2D approaches. But, when you start to observe and evaluate these same tissues in the 3D aspect, we are able to gain more insight into and it's apparent that we have a lot more to learn about what is going on inside the tumors.”
- Dr. Sharla White, VP of Research and Development

You May Also Be Interested In: